You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 1, January 1950 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

PENICILLIN IN THE TREATMENT OF EXPERIMENTAL SYPHILIS OF RABBITS

V. The Synergistic or Additive Activity of Penicillin Injected Intramuscularly with Sodium Iodide Administered Orally and Intravenously

JOHN A. KOLMER, M.D.

Arch Derm Syphilol. 1950;61(1):49-55.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ALTHOUGH the iodides have been employed in the treatment of syphilis since 1821, their mode of action has been obscure. Clinical experience has shown that they have little or no therapeutic effect in the early stages of the disease, this fact being due, it is commonly stated, to the absence of spirocheticidal activity. Thus Tomasczewski1 in 1910 reported that potassium iodide had no prophylactic or curative activity in the treatment of experimental syphilis of monkeys and rabbits. Nichols2 also reported that single intravenous injections of potassium iodide in doses of 0.01 and 0.03 Gm. per kilogram of body weight were ineffective in the treatment of 3 rabbits with acute testicular syphilis, although the intramuscular injection of 1 Gm. per kilogram into a fourth animal resulted in evidences of spirocheticidal activity. At the same time, however, Neisser3 reported that it was possible to prevent the development of . . . [Full Text PDF of this Article]


Author Affiliations

Professor of Medicine, Temple University School of Medicine and School of Dentistry; Director of the Research Institute of Cutaneous Medicine With the Technical Assistance of ANNA M. RULE PHILADELPHIA

From the Research Institute of Cutaneous Medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1950 American Medical Association. All Rights Reserved.